Gene Expression Signatures for Longevity Prediction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The existing understanding of gene expression changes in mammals is limited in explaining the variation in lifespan and phenotypic traits, with current models suggesting neutrality, but evidence suggests environmental and heritable factors play a significant role in shaping these traits, particularly in longevity.
Innovation Solution
Identification of gene expression signatures associated with longevity in mammals, where specific genes are upregulated or downregulated, allowing for the development of assays and methods to screen treatments that can modulate lifespan by comparing gene expression profiles to reference signatures.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If neutrality model is used to explain gene expression changes, then the explanation is simple and widely applicable, but it cannot account for environmental and heritable factors that significantly shape lifespan and phenotypic traits
Solution Approach 1:
The patent segments the complex phenomenon of gene expression changes into distinct components: heritable variation, environmental selection constraints, and neutral drift. By analyzing gene expression signatures in relation to lifespan and phenotypic traits separately, the patent can identify which factors contribute to longevity while maintaining a manageable analytical framework.
Solution Approach 2:
The patent introduces gene expression signatures as an intermediary layer between genetic variation and phenotypic outcomes. These signatures serve as mediators that integrate the effects of heritable factors and environmental influences, providing a comprehensive explanation for lifespan variation without oversimplifying the underlying mechanisms.
2Device complexity
If gene expression changes are assumed to have low predictable effects on phenotypes, then the complexity is reduced, but the ability to predict treatment effects on lifespan is compromised
Solution Approach 1:
The patent employs feedback mechanisms by comparing predicted gene expression signatures from treatments against observed outcomes in model organisms. This feedback loop allows refinement of predictive models, improving accuracy while managing complexity through iterative validation and adjustment of predictive algorithms.
Solution Approach 2:
The patent changes key parameters in the predictive model by focusing on specific gene expression signatures rather than attempting to predict all phenotypic outcomes. By selecting and weighting particular genes and expression patterns, the model achieves higher prediction accuracy for lifespan-related traits without requiring complete knowledge of all biological interactions.
3Reliability
If comprehensive analysis of gene expression and metabolites across multiple species is performed, then the understanding of longevity mechanisms is enhanced, but the computational and experimental resources required increase significantly
Solution Approach 1:
The patent applies local quality by focusing analysis on specific gene sets and pathways that are most relevant to longevity rather than treating all genes equally. By identifying and prioritizing key gene expression signatures associated with lifespan, the patent achieves reliable insights into longevity mechanisms while reducing the computational and experimental scope to manageable levels.
Solution Approach 2:
The patent employs partial action by analyzing subsets of genes and metabolites that show the most significant correlations with lifespan and phenotypic traits. This selective approach provides sufficient confidence in identified longevity mechanisms without requiring exhaustive analysis of all possible molecular interactions, thereby reducing resource requirements while maintaining scientific rigor.
Data Source
AI summary
The invention provides a collection of gene expression signatures that is linked to longevity. Also provided herein are assays, methods, and systems for identifying a treatment that can modulate lifespan or determining an effect of a treatment on a health profile of a subject by using the collection of gene expression signatures described herein.